Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:3.1.4.1 (phosphodiesterase)
 18,767 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Mouse trophoblast cells are constitutive producers of the thromboplastin apoprotein in vitro. The effects on thromboplastin activity of the three transmethylation inhibitors 3-deazaadenosine (DZA), 3-deazaaristeromycin (DZAri) and erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA), the four calcium antagonists TMB-8, verapamil, nifedipine and felodipine, the prostaglandin E2 (PGE2), the phosphodiesterase inhibitor 1-methyl 3-isobutylxanthine (MIX) and monensin have been studied. No cytotoxic effects were detected when trypan blue exclusion, release of lactic dehydrogenase, incorporation of 14C-leucine into protein and cell morphology were monitored. TMB-8, felodipine, nifedipine and verapamil all abolished the increase in thromboplastin when added after 68 hr or 90-96 hr in culture. EHNA and DZAri had the same effect (but were only added at 90-96 hr). DZA had a similar effect when added at 68 hr and an even more marked inhibitory effect when added at 90-96 hr. Monensin prevented the increase in thromboplastin activity at 68 hr as well as at 90-96 hr. The combination of DZA and 1-homocysteine thiolactone (Hcy) further increased the inhibition, indicating that in these cases synthesis as well as degradation of thromboplastin were altered. The combination of DZA/Hcy and one of the four calcium antagonists gave no additional inhibitory effect. PGE2 had a biphasic dose-dependent effect. The increased thromboplastin activity at low concentrations of PGE2 (10 ng/ml) was inhibited by addition of one of the compounds verapamil, felodipine, nifedipine or DZA/Hcy. PGE2 at higher levels (10 micrograms/ml) significantly inhibited thromboplastin synthesis. Combination of PGE2 (10 micrograms/ml) and one of the calcium antagonists, DZA/Hcy or MIX gave no significant additive inhibitory effect.
 ...
PMID:Effect of some drugs on thromboplastin activity in mouse trophoblast cells in vitro and in vivo. 242 64

The In-R1-G9 cell line is one of the clones derived from the In-111-R1 hamster insulinoma cell line and produces glucagon. The secretory responses of In-R1-G9 cells were further examined to characterize the nature of the cells. Vincristine had no effect on glucagon secretion and colchicine enhanced glucagon secretion slightly after a short incubation. Two calmodulin inhibitors, trifluoperazine and chlorpromazine, did not affect glucagon secretion. Monensin at 10(-8) M suppressed glucagon secretion by 50%. Secretion of glucagon was calcium-dependent. The addition of A23187 to the incubation medium resulted in a 180% increase over control for 1 h and calcium deprivation from the medium suppressed glucagon secretion markedly. Theophylline, a phosphodiesterase inhibitor, caused a 230% increase in glucagon secretion. An experiment using cycloheximide suggested that newly synthesized glucagon appears in the medium at 30 min. This cell line should be useful for various experiments in many fields of research.
 ...
PMID:Characterization of secretory responses of a glucagon-producing In-R1-G9 cell line. 283 60

In the presence of 10-100 microM monensin (a monovalent cation ionophore), a considerable amount of 125I activity of iodoinsulin accumulated in isolated rat epididymal adipocytes during a 30-min incubation. The accumulation was secondary to the action of monensin to inhibit dissociation of a certain fraction of the cellbound 125I activity. This monensin effect was reversible. The accumulation of 125I activity was ATP dependent and so was the discharge of the accumulated radioactivity. Approximately 91% of the accumulated radio-activity was precipitable with trichloroacetic acid, and at least 84% was reactive to anti-insulin antibody. Monensin at 100 microM appeared to have only mild effects on the cellular activities of glucose transport and cAMP phosphodiesterase. Nevertheless, when cells were first exposed to 10 nM insulin in the presence of 100 microM monensin and then transferred into a hormone-free buffer that contained monensin, the phosphodiesterase activity in cells remained partially activated as if cells were kept exposed to approximately 0.5 nM insulin. Under similar conditions, glucose transport activity remained partially activated as if cells were incubated with approximately 70 pM insulin. Monensin did not inhibit the reversal of the insulin effect per se. Like monensin, 20-100 microM chloroquine (a lysosomotropic inhibitor) induced a considerable accumulation of [125I] iodoinsulin. However, cells that had been exposed to insulin in the presence of chloroquine retained little hormonal effect after washing. Based on these observations and on the reported biological effects of monensin, it is suggested (a) that monensin may induce intracellular accumulation of the insulin-receptor complex by blocking the acidification of endocytic vesicles and (b) that the accumulated insulin-receptor complex may retain a weak, but significant, capacity to stimulate both glucose transport and phosphodiesterase activities.
 ...
PMID:Effects of monensin on insulin processing in adipocytes. Evidence that the internalized insulin-receptor complex has some physiological activities. 388 3